US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist
  • 17.430
  • +0.250+1.46%
Close Nov 21 16:00 ET
  • 17.430
  • 0.0000.00%
Post 16:02 ET
255.27MMarket Cap-2625P/E (TTM)

About Anika Therapeutics Company

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Company Profile

SymbolANIK
Company NameAnika Therapeutics
Listing DateNov 25, 1997
Founded1992
CEODr. Cheryl R. Blanchard, PhD
MarketNASDAQ
Employees357
Fiscal Year Ends12-31
Address32 Wiggins Avenue
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-457-9000

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Cheryl R. Blanchard, PhD
  • Director, President and Chief Executive Officer
  • 4.46M
  • Anne Nunes
  • Senior Vice President and Chief Operations Officer
  • 1.01M
  • Ian James Winward McLeod
  • Vice President and Chief Accounting Officer
  • --
  • Stephen D. Griffin
  • Executive Vice President, Chief Financial Officer and Treasurer
  • --
  • David Colleran
  • Executive Vice President, General Counsel and Secretary
  • 1.55M
  • John B. Henneman, III
  • Chairman of the Board
  • 249.81K
  • William R. Jellison
  • Independent Director
  • --
  • Joseph H. Capper
  • Independent Director
  • --
  • Susan L.N. Vogt
  • Independent Director
  • 248.98K
  • Dr. Glenn R. Larsen, PhD
  • Independent Director
  • 237.48K
  • Sheryl L. Conley
  • Independent Director
  • 242.48K
  • Gary P. Fischetti
  • Independent Director
  • 571.00K
  • Stephen O. Richard
  • Independent Director
  • 248.98K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data